JP2025510783A5 - - Google Patents
Info
- Publication number
- JP2025510783A5 JP2025510783A5 JP2024556445A JP2024556445A JP2025510783A5 JP 2025510783 A5 JP2025510783 A5 JP 2025510783A5 JP 2024556445 A JP2024556445 A JP 2024556445A JP 2024556445 A JP2024556445 A JP 2024556445A JP 2025510783 A5 JP2025510783 A5 JP 2025510783A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- domain contains
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323959P | 2022-03-25 | 2022-03-25 | |
| US63/323,959 | 2022-03-25 | ||
| PCT/US2023/064940 WO2023183926A1 (en) | 2022-03-25 | 2023-03-24 | Anti-cd94 antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510783A JP2025510783A (ja) | 2025-04-15 |
| JP2025510783A5 true JP2025510783A5 (enExample) | 2026-03-23 |
Family
ID=88102086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556445A Pending JP2025510783A (ja) | 2022-03-25 | 2023-03-24 | 抗ｃｄ９４抗体及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250197505A1 (enExample) |
| EP (1) | EP4499699A1 (enExample) |
| JP (1) | JP2025510783A (enExample) |
| CN (1) | CN119173536A (enExample) |
| WO (1) | WO2023183926A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030095965A1 (en) * | 2001-05-02 | 2003-05-22 | Katrien Van Beneden | Antibodies to Ly49E and CD94/NKG2 receptors |
| AU2015201622A1 (en) * | 2005-10-14 | 2015-04-16 | Innate Pharma | Compositions and methods for treating proliferative disorders |
| WO2020205440A1 (en) * | 2019-03-29 | 2020-10-08 | Dren Bio, Inc. | Methods of reducing large granular lymphocyte and natural killer cell levels |
| KR20230104611A (ko) * | 2020-09-30 | 2023-07-10 | 드렌 바이오, 인크. | 항-cd94 항체 및 이의 사용 방법 |
-
2023
- 2023-03-24 CN CN202380040037.4A patent/CN119173536A/zh active Pending
- 2023-03-24 WO PCT/US2023/064940 patent/WO2023183926A1/en not_active Ceased
- 2023-03-24 JP JP2024556445A patent/JP2025510783A/ja active Pending
- 2023-03-24 US US18/848,826 patent/US20250197505A1/en active Pending
- 2023-03-24 EP EP23775927.9A patent/EP4499699A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12024566B2 (en) | Anti-SIRPalpha antibody | |
| US20240287187A1 (en) | Bispecific antibody | |
| TWI771361B (zh) | 人程序性死亡受體pd-1的單株抗體及其片段 | |
| JP7366543B2 (ja) | Ｂｃｍａ結合分子及びその使用方法 | |
| JP2020513786A5 (enExample) | ||
| JP2020532965A5 (enExample) | ||
| CN113454119B (zh) | 抗btla抗体 | |
| JP2010504755A5 (enExample) | ||
| JP2016513467A5 (enExample) | ||
| JP2021525544A5 (enExample) | ||
| JP2019509014A5 (enExample) | ||
| JP7843824B2 (ja) | 抗体および使用方法 | |
| JP2022528721A5 (enExample) | ||
| JP2022521956A5 (enExample) | ||
| JP2022527084A5 (enExample) | ||
| JP2024535692A5 (enExample) | ||
| WO2023040940A1 (zh) | Pvrig/tigit结合蛋白联合免疫检查点抑制剂用于治疗癌症 | |
| JP2023543835A5 (enExample) | ||
| KR20210149044A (ko) | 이중 특이성 항체 | |
| CN115667311A (zh) | 抗cd40抗体组合治疗癌症 | |
| TW202118790A (zh) | 雙特異性抗體 | |
| JP2025510783A5 (enExample) | ||
| JP2024527576A5 (enExample) | ||
| CN120476151A (zh) | 用于治疗和抑制过敏性反应的组合物和方法 | |
| US20240287174A1 (en) | Hide1 compositions and methods |